Work

Design Considerations in the PSMAfore Trial

Year: 2024

Type: article

Abstract: In their article entitled “The Imperative for Comparative Studies in Nuclear Medicine: Elevating 177Lu-PSMA-617 in the Treatment Paradigm for mCRPC” in The Journal of Nuclear Medicine, Rahbar et al. make some important comments ([1][1]). On behalf of the coauthors of the PSMAfore presentation

Source: Journal of Nuclear Medicine

DOI: 10.2967/jnumed.123.267034

Authors: Oliver Sartor, Karim Fizazi, Ken Herrmann, Michael J. Morris

Institutions: Mayo Clinic, Institut Gustave Roussy, Essen University Hospital, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4391449922